Endophthalmitis following same-day bilateral anti-VEGF injections

Endophthalmitis following same-day bilateral anti-VEGF injections: a systematic review

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Endophthalmitis following same-day bilateral anti-VEGF injections : a systematic review. / Bjerager, Jakob; Hajari, Javad; Klefter, Oliver Niels; Subhi, Yousif; Schneider, Miklos.

I: International Ophthalmology, Bind 44, Nr. 1, 2024, s. 37.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Bjerager, J, Hajari, J, Klefter, ON, Subhi, Y & Schneider, M 2024, 'Endophthalmitis following same-day bilateral anti-VEGF injections: a systematic review', International Ophthalmology, bind 44, nr. 1, s. 37. https://doi.org/10.1007/s10792-024-02983-4

APA

Bjerager, J., Hajari, J., Klefter, O. N., Subhi, Y., & Schneider, M. (2024). Endophthalmitis following same-day bilateral anti-VEGF injections: a systematic review. International Ophthalmology, 44(1), 37. https://doi.org/10.1007/s10792-024-02983-4

Vancouver

Bjerager J, Hajari J, Klefter ON, Subhi Y, Schneider M. Endophthalmitis following same-day bilateral anti-VEGF injections: a systematic review. International Ophthalmology. 2024;44(1):37. https://doi.org/10.1007/s10792-024-02983-4

Author

Bjerager, Jakob ; Hajari, Javad ; Klefter, Oliver Niels ; Subhi, Yousif ; Schneider, Miklos. / Endophthalmitis following same-day bilateral anti-VEGF injections : a systematic review. I: International Ophthalmology. 2024 ; Bind 44, Nr. 1. s. 37.

Bibtex

@article{68cc3740214d481caa276891348f1590,

title = "Endophthalmitis following same-day bilateral anti-VEGF injections: a systematic review",

abstract = "PURPOSE: To review the risk of endophthalmitis in same-day bilateral anti-VEGF injections. METHODS: We searched 12 literature databases for studies on the risk of endophthalmitis after same-day bilateral intravitreal anti-VEGF injections. Data extraction was made independently by two authors and discussed afterward until reaching consensus. RESULTS: Seventeen studies were included with a total of 138,478 intravitreal anti-VEGF injections (69,239 bilateral injections sessions) given in at least 7579 patients. In total, 33 cases of endophthalmitis had occurred, and no cases were bilateral. The incidence of endophthalmitis ranged from 0 to 0.53% per intravitreal injection across studies. CONCLUSIONS: We suggest that clinicians can consider same-day treatment of both eyes of patients in need of bilateral intravitreal anti-VEGF injection therapy, but larger studies are needed to quantify the exact risk of endophthalmitis.",

keywords = "Adverse event, Anti-VEGF, Bilateral, Endophthalmitis, Injection, Intravitreal, Risk, Same-day, Same-session, Systematic review",

author = "Jakob Bjerager and Javad Hajari and Klefter, {Oliver Niels} and Yousif Subhi and Miklos Schneider",

note = "Publisher Copyright: {\textcopyright} 2024. The Author(s), under exclusive licence to Springer Nature B.V.",

year = "2024",

doi = "10.1007/s10792-024-02983-4",

language = "English",

volume = "44",

pages = "37",

journal = "International Ophthalmology",

issn = "0165-5701",

publisher = "Springer",

number = "1",

}

RIS

TY - JOUR

T1 - Endophthalmitis following same-day bilateral anti-VEGF injections

T2 - a systematic review

AU - Bjerager, Jakob

AU - Hajari, Javad

AU - Klefter, Oliver Niels

AU - Subhi, Yousif

AU - Schneider, Miklos

PY - 2024

Y1 - 2024

N2 - PURPOSE: To review the risk of endophthalmitis in same-day bilateral anti-VEGF injections. METHODS: We searched 12 literature databases for studies on the risk of endophthalmitis after same-day bilateral intravitreal anti-VEGF injections. Data extraction was made independently by two authors and discussed afterward until reaching consensus. RESULTS: Seventeen studies were included with a total of 138,478 intravitreal anti-VEGF injections (69,239 bilateral injections sessions) given in at least 7579 patients. In total, 33 cases of endophthalmitis had occurred, and no cases were bilateral. The incidence of endophthalmitis ranged from 0 to 0.53% per intravitreal injection across studies. CONCLUSIONS: We suggest that clinicians can consider same-day treatment of both eyes of patients in need of bilateral intravitreal anti-VEGF injection therapy, but larger studies are needed to quantify the exact risk of endophthalmitis.

AB - PURPOSE: To review the risk of endophthalmitis in same-day bilateral anti-VEGF injections. METHODS: We searched 12 literature databases for studies on the risk of endophthalmitis after same-day bilateral intravitreal anti-VEGF injections. Data extraction was made independently by two authors and discussed afterward until reaching consensus. RESULTS: Seventeen studies were included with a total of 138,478 intravitreal anti-VEGF injections (69,239 bilateral injections sessions) given in at least 7579 patients. In total, 33 cases of endophthalmitis had occurred, and no cases were bilateral. The incidence of endophthalmitis ranged from 0 to 0.53% per intravitreal injection across studies. CONCLUSIONS: We suggest that clinicians can consider same-day treatment of both eyes of patients in need of bilateral intravitreal anti-VEGF injection therapy, but larger studies are needed to quantify the exact risk of endophthalmitis.

KW - Adverse event

KW - Anti-VEGF

KW - Bilateral

KW - Endophthalmitis

KW - Injection

KW - Intravitreal

KW - Risk

KW - Same-day

KW - Same-session

KW - Systematic review

U2 - 10.1007/s10792-024-02983-4

DO - 10.1007/s10792-024-02983-4

M3 - Review

C2 - 38332399

AN - SCOPUS:85184791009

VL - 44

SP - 37

JO - International Ophthalmology

JF - International Ophthalmology

SN - 0165-5701

IS - 1

ER -

ID: 383705291

Institut for Idræt og Ernæring